M1 |
LPS, IFN-γ |
iNOS, IL-1β, IL-6, IL-12, IL-15, IL-18, TNF-α, CCL-15, -20, CXCL-9, -10, -11 |
MHCII, CD86, TLR, IFN-γR |
Phagocytose bacteria and debris, attract immune cells, tissue damage, clearance of intracellular pathogens, pro-inflammatory |
(8–12) |
M2 |
M2a |
IL-4, IL-13, IL-33 |
IL-10, IL-12, CCL-13, -14, -17, -18, 22, 23, 24, 26, IGF-1, arginase, FIZZ1, YM1 |
MR, GR, SR, CD 163, CD23 |
Support ECM deposition wound closure, angiogenesis, promotion of allergic responses, anti-inflammatory |
(13–15) |
M2b |
Immune complexes, IL-1β, LPS |
IL-10, CCL-1, -20, CXCL-1, -2, -3 |
IL-1R, IL-10R, TLR4, FcγR |
Suppress inflammation via high IL-10, immuneregulation, |
(16–19) |
M2c |
IL-10, GC, TGF-β |
CCL-16, 18, CXCL-13, TGF-β, BMP-2 |
CD163, CD206, IL-10R, PD-1 |
Suppress inflammation via IL-10, produce ECM and MMPs for vascular/matric remodeling, tissue remodeling |
(20–22) |
M2d |
IL-6 and adenosine |
VEGF, IL-10, IL-12, TNF-α, TGF-β |
--- |
Aids in angiogenesis via VEGF |
(23–25) |